Camille Bachelet, PhD
@camillebachelet.bsky.social
Passionate about cell therapy, I explore innovative technologies to advance the field. Curious and always learning, I enjoy exchanging ideas on biotechnology and regenerative medicine.
Link of the study: pubmed.ncbi.nlm.nih.gov/39753970/
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial - PubMed
New treatment approaches are warranted for patients with advanced melanoma refractory to immune checkpoint blockade (ICB) or BRAF-targeted therapy. We designed BNT221, a personalized, neoantigen-speci...
pubmed.ncbi.nlm.nih.gov
February 4, 2025 at 1:00 PM
Link of the study: pubmed.ncbi.nlm.nih.gov/39753970/